| P2093 | author name string | Li Zhang | |
| | Yue Chen | |
| | Yan Huang | |
| | Hongyun Zhao | |
| | Ting Zhou | |
| | Cong Xue | |
| | Shaodong Hong | |
| | Tao Qin | |
| | Wenfeng Fang | |
| | Yanna Tang | |
| | Yuanyuan Zhao | |
| | Yuxiang Ma | |
| | Xue Hou | |
| | Yunpeng Yang | |
| | Zhihuang Hu | |
| P2860 | cites work | Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer. | Q51063023 |
| | CEA is an independent prognostic indicator that is associated with reduced survival and liver metastases in SCLC. | Q51554114 |
| | Serum albumin as a stable predictor of prognosis during initial treatment in patients with diffuse large B cell lymphoma. | Q53033988 |
| | [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients] | Q70507813 |
| | The impact of anemia on outcome of chemoradiation for limited small-cell lung cancer: a combined analysis of studies of the National Cancer Institute of Canada Clinical Trials Group | Q80516016 |
| | Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer | Q83812130 |
| | Small-cell lung cancer | Q84084759 |
| | The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage | Q86282781 |
| | Inflammation and cancer | Q24649640 |
| | Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis | Q27001079 |
| | Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis | Q27022482 |
| | Cancer-related inflammation | Q27860907 |
| | Cancer statistics, 2014 | Q27861018 |
| | Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients | Q28246500 |
| | Lung cancer | Q29615473 |
| | Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response | Q30843051 |
| | Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 s | Q33411909 |
| | Chronic inflammation and cytokines in the tumor microenvironment | Q33678275 |
| | The pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma | Q35144019 |
| | A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI) | Q35889913 |
| | An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research | Q35981709 |
| | Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres | Q36135716 |
| | Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization | Q36467712 |
| | An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. | Q37152934 |
| | Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas | Q37416054 |
| | Nutritional intervention for improving treatment tolerance in cancer patients | Q37873288 |
| | The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. | Q38045094 |
| | Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score. | Q38169857 |
| | Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol | Q38219586 |
| | Therapy of small cell lung cancer: a perspective on two decades of clinical research | Q39221006 |
| | Serum albumin | Q39635797 |
| | Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program | Q40251202 |
| | A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease. | Q43128788 |
| | Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: Long-term outcomes of 512 patients from a single institution. | Q43429758 |
| | Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years | Q43517625 |
| | Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma | Q43875251 |
| | Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy | Q44808739 |
| | Small cell lung cancer--state of the art and future perspectives | Q46979299 |
| | Pretreatment serum lactate dehydrogenase as additional staging parameter in patients with small-cell lung carcinoma | Q47995632 |
| | Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. | Q48477176 |
| | Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer. | Q48633897 |
| P433 | issue | 5 | |
| P304 | page(s) | 3389-3397 | |
| P577 | publication date | 2014-12-20 | |
| P1433 | published in | Tumor Biology | Q15757842 |
| P1476 | title | The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients | |
| P478 | volume | 36 | |